Impilo is focused on healthcare investments in Nordic regions.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products 1 Services tracked
Competitors - Brand Intelligence

About Impilo

Impilo is a company based in Stockholm (Sweden). It operates as a Brokerage / Intermediation. Impilo has completed 11 acquisitions, including Decon, Euro Accident and Immedica. Impilo offers products and services including Healthcare Investments.

  • Headquarter Stockholm, Sweden
  • Sectors
    Financial Services
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Financial Services → FinTech & Digital Finance Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
  • Investments & Acquisitions
    Decon

    & 10 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Impilo

Impilo offers a comprehensive portfolio of products and services, including Healthcare Investments.

Product name locked
Category locked
Primary

Investments in healthcare companies are managed and supported.

Funding Insights of Impilo

Premium access

Detailed funding history for Impilo

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Impilo

Impilo has strategically engaged in corporate development activities, having acquired 11 companies. Notable acquisitions include Decon, Euro Accident and Immedica.

Investments
Premium access

Investment portfolio details for Impilo

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Therapeutic agents for oncology, neurology, and related diseases are developed.
Locked Locked 2017 Locked
A chain of dental clinics is operated in Denmark.
Locked Locked 2016 Locked
Chain of fertility clinics
Locked Locked 2015 Locked
Premium access

Complete acquisition details for Impilo

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Impilo

Premium access

Detailed financials for Impilo

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Impilo Comparisons

Impilo Primary company
Description
Impilo is focused on healthcare investments in Nordic region...
Location
Stockholm, Sweden
Founded Year
-
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Impilo

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Impilo

Premium access

Detailed competitors of Impilo

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Impilo

Premium access

Complete news archive for Impilo

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Impilo

Impilo is headquartered in Stockholm, Sweden.

Impilo is engaged as a Nordic investment company specializing in the healthcare sector. Investments are made in pharmaceutical, medtech, specialist pharma services, and related healthcare industries. Portfolio companies are supported to ensure sustainable development within their markets. The focus is placed on positive health impacts and sustainability of healthcare systems. Target companies are evaluated based on their potential to improve quality of care, increase availability, lower costs, and prevent the need for care. Investments are structured to double operating profits over five years while outperforming relevant markets.

Impilo offers Healthcare Investments.

Impilo has made 11 acquisitions, including Decon, Euro Accident, and Immedica.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available